Nectar Lifesciences Limited (NECLIFE.NS) NSE

21.14

-1.11(-4.99%)

Updated at December 24 03:28PM

Currency In INR

Nectar Lifesciences Limited

Address

SCO 38-39

Chandigarh, 160009

India

Phone

91 17 2304 7777

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1686

First IPO Date

July 18, 2005

Key Executives

NameTitlePayYear Born
Amit ChadahChief Executive Officer01970
Sanjiv GoyalChairman & MD21.61M1960
Surulichamy SenthilkumarDirector of R&D and Additional Whole Time Director01973
SinghPresident0N/A
Sanjaymohan Singh RawatCompany Secretary & Compliance Officer0N/A
Sushil KapoorCFO, Wholetime Director of Finance & Additional Director01958

Description

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.